GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated March 25, 2024, serves as a notice of the publication of the Annual General Meeting (AGM) 2024. The filing is a procedural disclosure required under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 and does not contain financial results for a specific reporting period.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics. This document is strictly an announcement regarding corporate governance procedures.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling and logistics of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
There is no management commentary, financial guidance, outlook, or discussion of risks and contingencies in this filing. The document confirms that the AGM will be held on Wednesday, May 8, 2024, at 2:30 pm at the Royal Lancaster London, with options for electronic participation. It also notes compliance with UK FCA Listing Rules regarding the submission of the AGM Notice and Proxy Form.
Key Facts for Investors to Verify
- AGM Date: Wednesday, May 8, 2024.
- AGM Location: Royal Lancaster London, Lancaster Terrace, London W2 2TY.
- Availability of the full AGM Notice and Proxy Form on the company website and the FCA National Storage Mechanism.
- Procedures for joining the meeting in person or electronically as detailed in the AGM Guide.